Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Dova Pharmaceuticals (NASDAQ:DOVA) shares were up 38.5% to $27.99 after the company announced it would be acquired by Orphan Biovitrum for $29 per share, of which $27.50 is to be paid upfront in cash.
- Bed Bath & Beyond (NASDAQ:BBBY) shares were up 7% to $10.58. Wedbush upgraded the stock from Neutral to Outperform and raised the price target from $14 to $16.
- TrovaGene (NASDAQ:TROV) shares were up 14.5% to $1.68 after the company reported positive data from its phase 1b/2 study of onvansertib in patients with relapsed/refractory acute myeloid leukmia.
- Mallinckroft (NYSE:MNK) shares were up 1.8% to $2.29 after the company reported it settled opiod cases in Cuyahoga and Summit counties in Ohio.
- Sienna Biopharmaceuticals (NASDAQ:SNNA) shares were up 57% to $0.18 on higher the average volume at 25 million shares traded for the session.
- Seattle Genetics(NASDAQ:SGEN) shares were up 11.4% to $84.70 after after Piper Jaffray maintained an Overweight rating on the stock and raised the price target from $75 to $95. The company presented compelling initial data from the EV-103 study, which compared favorably to the current standard of care.
- Micron Technology (NASDAQ:MU) shares were down 0.9% to $42.84.
- Newell Brands (NASDAQ:NWL) shares were up 6.7% to $19.42. SunTrust Robinson Humphrey upgraded the stock from Hold to Buy and raised the price target from $15 to $25 per share.
- Immunomedics (NASDAQ:IMMU) shares were down 13.7% to $12.37 after the interim data from its phase 2 study of sacituzumab govitecan showed a 29% response rate.
- Alibaba Group Holding (NYSE:BABA) shares were up 1.6% to $168.76.